Lv1
10 积分 2024-09-05 加入
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
1小时前
待确认
Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti‐PD‐1 monotherapy
2个月前
已完结
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma
3个月前
已完结
Radiotherapy and immunotherapy: a beneficial liaison?
5个月前
已完结
Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma
5个月前
已完结
黑色素瘤靶点及其靶向治疗药物
5个月前
已关闭
Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single‐arm clinical trial
7个月前
已完结
Preoperative (neoadjuvant) therapy with tislelizumab for locally advanced colorectal cancer with high microsatellite instability or deficient mismatch repair: An open-label, single-arm, multicenter phase II study
7个月前
已完结
Utilization of hypofractionated radiation therapy in older glioblastoma patients
10个月前
已完结
Utilization of hypofractionated radiation therapy in older glioblastoma patients
10个月前
已关闭
皖公网安备34019202002308
